Literature DB >> 16444255

Evidence for an instructive mechanism of de novo methylation in cancer cells.

Ilana Keshet1, Yeshayahu Schlesinger, Shlomit Farkash, Eyal Rand, Merav Hecht, Eran Segal, Eli Pikarski, Richard A Young, Alain Niveleau, Howard Cedar, Itamar Simon.   

Abstract

DNA methylation has a role in the regulation of gene expression during normal mammalian development but can also mediate epigenetic silencing of CpG island genes in cancer and other diseases. Many individual genes (including tumor suppressors) have been shown to undergo de novo methylation in specific tumor types, but the biological logic inherent in this process is not understood. To decipher this mechanism, we have adopted a new approach for detecting CpG island DNA methylation that can be used together with microarray technology. Genome-wide analysis by this technique demonstrated that tumor-specific methylated genes belong to distinct functional categories, have common sequence motifs in their promoters and are found in clusters on chromosomes. In addition, many are already repressed in normal cells. These results are consistent with the hypothesis that cancer-related de novo methylation may come about through an instructive mechanism.

Entities:  

Mesh:

Year:  2006        PMID: 16444255     DOI: 10.1038/ng1719

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  173 in total

Review 1.  Epigenetic regulation and measurement of epigenetic changes.

Authors:  Kimberly E Stephens; Christine A Miaskowski; Jon D Levine; Clive R Pullinger; Bradley E Aouizerat
Journal:  Biol Res Nurs       Date:  2012-06-03       Impact factor: 2.522

Review 2.  Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Authors:  Satish Kalari; Gerd P Pfeifer
Journal:  Adv Genet       Date:  2010       Impact factor: 1.944

3.  Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells.

Authors:  Limin Shu; Tin Oo Khor; Jong-Hun Lee; Sarandeep S S Boyanapalli; Ying Huang; Tien-Yuan Wu; Constance L-L Saw; Ka-Lung Cheung; Ah-Ng Tony Kong
Journal:  AAPS J       Date:  2011-09-22       Impact factor: 4.009

4.  Associations with early-life socio-economic position in adult DNA methylation.

Authors:  Nada Borghol; Matthew Suderman; Wendy McArdle; Ariane Racine; Michael Hallett; Marcus Pembrey; Clyde Hertzman; Chris Power; Moshe Szyf
Journal:  Int J Epidemiol       Date:  2011-10-20       Impact factor: 7.196

Review 5.  Methods in DNA methylation profiling.

Authors:  Tao Zuo; Benjamin Tycko; Ta-Ming Liu; Juey-Jen L Lin; Tim H-M Huang
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

6.  Direct DNA methylation profiling using methyl binding domain proteins.

Authors:  Yinni Yu; Steve Blair; David Gillespie; Randy Jensen; David Myszka; Ahmed H Badran; Indraneel Ghosh; Alexander Chagovetz
Journal:  Anal Chem       Date:  2010-06-15       Impact factor: 6.986

Review 7.  Identifying molecular markers for the early detection of pancreatic neoplasia.

Authors:  Michael Goggins
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

8.  Comparative isoschizomer profiling of cytosine methylation: the HELP assay.

Authors:  Batbayar Khulan; Reid F Thompson; Kenny Ye; Melissa J Fazzari; Masako Suzuki; Edyta Stasiek; Maria E Figueroa; Jacob L Glass; Quan Chen; Cristina Montagna; Eli Hatchwell; Rebecca R Selzer; Todd A Richmond; Roland D Green; Ari Melnick; John M Greally
Journal:  Genome Res       Date:  2006-06-29       Impact factor: 9.043

9.  Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA.

Authors:  Meir Shamay; Anita Krithivas; Jun Zhang; S Diane Hayward
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-18       Impact factor: 11.205

Review 10.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.